Factors associated with the elevated percentage of CD4CD69 T cells in maintained hemodialysis patients

References

• Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013;9:255–265.
   PubMed Web of Science ®Google Scholar
• Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3:1526–1533.
   PubMed Web of Science ®Google Scholar
• LV Wen-lv TJ, Yi-hong Z, Jian-zhou Z, et al. Analysis of the death causes in patients treated with hemodialysis. Chin J Nephrol Dial Transplant. 2011;20:8.
   Google Scholar
• Meijers RW, Litjens NH, de Wit EA, et al. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients. Immun Ageing. 2012;9:19.
   PubMed Web of Science ®Google Scholar
• Meijers RW, Betjes MG, Baan CC, et al. T-cell ageing in end-stage renal disease patients: assessment and clinical relevance. WJN. 2014;3:268–276.
   Google Scholar
• Betjes MG, Meijers RW, Litjens NH. Loss of renal function causes premature aging of the immune system. Blood Purif. 2013;36:173–178.
   PubMed Web of Science ®Google Scholar
• Yoon JW, Gollapudi S, Pahl MV, et al. Naïve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006;70:371–376.
   PubMed Web of Science ®Google Scholar
• Betjes MG, Meijers RW, de Wit LE, et al. A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients. J Nephrol. 2012;25:183–191.
   PubMed Web of Science ®Google Scholar
• Betjes MG, de Wit EE, Weimar W, et al. Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol Dial Transplant. 2010;25:3640–3646.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758–1764.
   PubMed Web of Science ®Google Scholar
• Litjens NH, Huisman M, van den Dorpel M, et al. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol. 2008;19:1483–1490.
   PubMed Web of Science ®Google Scholar
• Verkade MA, van de Wetering J, Klepper M, et al. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int. 2004;66:614–621.
   PubMed Web of Science ®Google Scholar
• Stewart JH, Vajdic CM, van Leeuwen MT, et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009;24:3225–3231.
   PubMed Web of Science ®Google Scholar
• Nagy A, Walter E, Zubakov D, et al. High risk of development of renal cell tumor in end-stage kidney disease: the role of microenvironment. Tumour Biol. 2016;37:9511–9519.
   PubMed Web of Science ®Google Scholar
• Abbas A, Lichtman AH, Pillai S, editors. Cells and tissues of the immune system (Chapter 2). In: Cellular and molecular immunology. 8th ed. Philadelphia, PA: Elsevier; 2015. p. 18–19.
   Google Scholar
• Betjes MG, Huisman M, Weimar W, et al. Expansion of cytolytic CD4 + CD28-T cells in end-stage renal disease. Kidney Int. 2008;74:760–767.
   PubMed Web of Science ®Google Scholar
• Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry. 1997;27:71–76.
   PubMedGoogle Scholar
• Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells. 1994;12:456–465.
   PubMed Web of Science ®Google Scholar
• Nielsen SD, Afzelius P, Ersboll AK, et al. Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients. Clin Exp Immunol. 1998;114:66–72.
   PubMed Web of Science ®Google Scholar
• Bohler T, Walcher J, Holzl-Wenig G, et al. Expression of CD69 on T-cells from HIV-1-infected children and adolescents increases with increasing viral load. Eur J Pediatr. 1999;158:638–644.
   PubMed Web of Science ®Google Scholar
• Beeler A, Zaccaria L, Kawabata T, et al. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy. 2008;63:181–188.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–869.
   PubMed Web of Science ®Google Scholar
• Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277:112–116.
   PubMed Web of Science ®Google Scholar
• Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5:133–139.
   PubMed Web of Science ®Google Scholar
• Meier P, Dayer E, Blanc E, et al. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:204–212.
   PubMed Web of Science ®Google Scholar
• Almeida A, Lourenco O, Fonseca AM. Haemodialysis in diabetic patients modulates inflammatory cytokine profile and T cell activation status. Scand J Immunol. 2015;82:135–141.
   PubMed Web of Science ®Google Scholar
• Wang H, Hou L, Kwak D, et al. Increasing regulatory T cells with interleukin-2 and interleukin-2 antibody complexes attenuates lung inflammation and heart failure progression. Hypertension. 2016;68:114–122.
   PubMed Web of Science ®Google Scholar
• Wang H, Kwak D, Fassett J, et al. CD28/B7 deficiency attenuates systolic overload-induced congestive heart failure, myocardial and pulmonary inflammation, and activated T cell accumulation in the heart and lungs. Hypertension. 2016;68:688–696.
   PubMed Web of Science ®Google Scholar
• Liu L, Lee J, Fu G, et al. Activation of peripheral blood CD3(+) T-lymphocytes in patients with atrial fibrillation. Int Heart J. 2012;53:221–224.
   PubMed Web of Science ®Google Scholar
• Acuna-Valerio J, Rodas-Diaz MA, Macias-Garrido E, et al. [Aortic valve calcification prevalence and association with coronary risk factors and atherosclerosis in Mexican population]. Archivos De Cardiologia De Mexico. 2016;87:108–115.
   PubMed Web of Science ®Google Scholar
• Hoffmann U, Massaro JM, D’Agostino RB Sr, et al. Cardiovascular event prediction and risk reclassification by coronary, aortic, and valvular calcification in the Framingham Heart Study. J Am Heart Assoc. 2016;5:1–5.
   Web of Science ®Google Scholar
• Wu HD, Maurer MS, Friedman RA, et al. The lymphocytic infiltration in calcific aortic stenosis predominantly consists of clonally expanded T cells. J Immunol. 2007;178:5329–5339.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989;135:169–175.
   PubMed Web of Science ®Google Scholar
• Jonasson L, Holm J, Skalli O, et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131–138.
   PubMedGoogle Scholar
• Mosorin M, Surcel HM, Laurila A, et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol. 2000;20:1061–1067.
   PubMed Web of Science ®Google Scholar
• Zhang X, Niessner A, Nakajima T, et al. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res. 2006;98:7.
   PubMed Web of Science ®Google Scholar
• Carr SC, Farb A, Pearce WH, et al. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery. 1997;122:757–763.
   PubMed Web of Science ®Google Scholar
• Blumenkrantz MJ, Kopple JD, Gutman RA, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr. 1980;33:1567–1585.
   PubMed Web of Science ®Google Scholar
• Faulk WP, Demaeyer EM, Davies AJ. Some effects of malnutrition on the immune response in man. Am J Clin Nutr. 1974;27:638–646.
   PubMed Web of Science ®Google Scholar
• Guo W, Zheng W, Luo Q, et al. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells. Inorg Chem. 2013;52:5328–5338.
   PubMed Web of Science ®Google Scholar
• Lum JB, Infante AJ, Makker DM, et al. Transferrin synthesis by inducer T lymphocytes. J Clin Invest. 1986;77:841–849.
   PubMed Web of Science ®Google Scholar
• Besin G. [Magnesium transporter protein 1, a new intermediate in TCR signaling]. Med Sci (Paris). 2012;28:568–570.
   PubMed Web of Science ®Google Scholar
• de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95:1–46.
   PubMed Web of Science ®Google Scholar
• Chung HS, Park CS, Hong SH, et al. Effects of magnesium pretreatment on the levels of T helper cytokines and on the severity of reperfusion syndrome in patients undergoing living donor liver transplantation. Magnesium Res. 2013;26:46–55.
   PubMed Web of Science ®Google Scholar
• Liang RY, Wu W, Huang J, et al. Magnesium affects the cytokine secretion of CD4(+) T lymphocytes in acute asthma. J Asthma. 2012;49:1012–1015.
   PubMed Web of Science ®Google Scholar
• Litjens NHR, de Wit EA, Betjes MGH. Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Ageing. 2011;8:1–10.
   PubMed Web of Science ®Google Scholar